Is Eurofins Amatsi Analytics FDA approved?

Eurofins Amatsi Analytics holds 3 FDA-registered establishments in France. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Eurofins Amatsi Analytics's registered sites?

The FDA register lists Fontenilles; Peyruis; Saint-Augustin. Registered operations: analytical testing.

Eurofins Amatsi Analytics

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 3
Active NDC listings: 0
Live patents: 0
Countries: 1
Base: France

Authorisation

Registered operations

Analytical testing3

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Eurofins Amatsi Analytics	Parc De Genibrat, Fontenilles, 31470, France (FRA)	Analytical testing	3006118993270324185
Eurofins Amatsi Analytics	ZA du Mardaric, Peyruis, 04310, France (FRA)	Analytical testing	3012886212271740939
Eurofins Amatsi Analytics	Le Bourg, Saint-Augustin, 19390, France (FRA)	Analytical testing	3018901110271768795

Compare

Comparable companies in France

PCAS3 sites · 20 NDC
Pierre Fabre Pharmaceuticals, Inc.3 sites · 13 NDC
Unither Manufacturing LLC3 sites · 6 NDC
Boehringer Ingelheim Animal Health USA Inc.3 sites · 0 NDC
Ethypharm3 sites · 0 NDC
Novacyl2 sites · 19 NDC
Guerbet LLC2 sites · 14 NDC
Finorga2 sites · 9 NDC
Biocodex2 sites · 4 NDC
Albhades Provence2 sites · 0 NDC

Enquiry

Common questions

Is Eurofins Amatsi Analytics FDA approved?: Eurofins Amatsi Analytics holds 3 FDA-registered establishments in France. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Eurofins Amatsi Analytics's registered sites?: The FDA register lists Fontenilles; Peyruis; Saint-Augustin. Registered operations: analytical testing.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.